Molnupiravir: Mechanism of Action
Molnupiravir is an antiviral medication used for the treatment of mild to moderate COVID-19 in adults. It works by introducing errors into the viral RNA, leading to the inhibition of viral replication.
Category
Drug
Where to get
Emergency use authorization in some regions for COVID-19 treatment.
Applicable for
Prepared by Shruti Sahoo, reviewed by Dr. Eugene Smith
Molnupiravir References
If you want to know more about Molnupiravir, consider exploring links below:
What Is Molnupiravir
- https://www.drugs.com/molnupiravir.html
- https://www.yalemedicine.org/news/9-things-to-know-about-covid-pill
- https://www.covid19treatmentguidelines.nih.gov/therapies/antivirals-including-antibody-products/molnupiravir/
- https://www.sahealth.sa.gov.au/wps/wcm/connect/9326c59a-6509-4065-b705-d16f04ac4de6/COVID-19+Treatment+Fact+sheet+-+Molnupiravir+-+Patients+FINAL+June+2022.pdf?MOD=AJPERES
- https://en.wikipedia.org/wiki/Molnupiravir
- https://www.health.wa.gov.au/~/media/Corp/Documents/Health-for/Infectious-disease/COVID19/Molnupiravir-Lagevrio-what-prescribers-and-pharmacists-need-to-know.pdf
- https://www.cec.health.nsw.gov.au/__data/assets/pdf_file/0008/702818/Information-for-patients-family-and-carers-molnupiravir.PDF
- https://www.who.int/news/item/03-03-2022-molnupiravir
- https://www.tga.gov.au/news/media-releases/tga-provisionally-approves-two-oral-covid-19-treatments-molnupiravir-lagevrio-and-nirmatrelvir-ritonavir-paxlovid